Combined Hormonal Contraceptive Use in High Risk Women: A Longitudinal Study
NCT00361400 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1387
Last updated 2013-08-02
Summary
This study is an examination of "high risk" young women, 15-24 years of age, who initiate first time use of vaginal ring, oral contraceptives, contraceptive path, or Depo-provera.
Conditions
- Pregnancy
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Tina R Raine, MD, MPH · University of California, San Francisco
-
Cynthia Harper, PhD · University of California, San Francisco
Eligibility
- Min Age
- 15 Years
- Max Age
- 24 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-08-31
- Primary Completion
- 2008-09-30
- Completion
- 2008-09-30
Countries
- United States
Study Locations
More Related Trials
-
Duration of Use of Highly Effective Reversible Contraception
NCT02414919 ·Status: COMPLETED
-
Oral Contraceptive Pills Compared to Vaginal Rings
NCT00357526 ·Status: COMPLETED ·Phase: NA
-
Quick Start of Highly Effective Contraception
NCT02076217 ·Status: COMPLETED
-
Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles
NCT05139121 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Safety and Efficacy of an Oral Contraceptive
NCT00391807 ·Status: COMPLETED ·Phase: PHASE3
-
Continuous Use of COCs
NCT00570440 ·Status: COMPLETED ·Phase: PHASE4
-
Hormonal Management of Heavy Menstrual Bleeding in Adolescents
NCT06740929 ·Status: RECRUITING
-
Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive
NCT00196326 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
NCT00995150 ·Status: TERMINATED ·Phase: PHASE3
-
Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis
NCT02367833 ·Status: COMPLETED ·Phase: PHASE4
-
Contraceptive Counseling in the Postpartum Period
NCT02380781 ·Status: COMPLETED ·Phase: NA
-
Research Study to Investigate the Effect of NNC0174-0833 on a Birth Control Pill in Women Who Are Not Able to Become Pregnant
NCT04074174 ·Status: COMPLETED ·Phase: PHASE1
-
Low Dose Continuous Administration of the Progesterone Receptor Modulator VA2914
NCT00456924 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Contraceptive Hormone-free Interval Pituitary/ Ovarian Activity
NCT01953211 ·Status: COMPLETED
-
Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding
NCT03642210 ·Status: COMPLETED ·Phase: PHASE3
-
Quick Start Approach to Birth Control Pills
NCT00068848 ·Status: COMPLETED ·Phase: PHASE4
-
A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
NCT01252186 ·Status: COMPLETED ·Phase: PHASE2
-
Patient Compliance With Long-Acting Reversible Contraception Administration
NCT03305081 ·Status: TERMINATED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
NCT01178125 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-center, Open-label, Randomized, Parallel Group Study to Evaluate Pharmacokinetic Profile, Effects on the Mechanisms of Contraceptive Efficacy and Safety of Two Progestin-only Patches Containing Different Doses of Levonorgestrel (LNG)
NCT01166412 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Obesity, Oral Contraception, and Ovarian Suppression
NCT00827632 ·Status: COMPLETED ·Phase: PHASE4
-
Norethindrone for the Delay of Menstruation
NCT03594604 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function
NCT01257984 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062)
NCT02616146 ·Status: TERMINATED ·Phase: PHASE3
-
Postpartum Etonogestrel Implant for Adolescents
NCT01666912 ·Status: COMPLETED ·Phase: PHASE4